Analytical testing services
to ensure quality and compliance

Curia offers a complete suite of analytical testing services and method development for biologics and small molecule therapeutics.

Complete suite of analytical testing services
for biologics and small molecules

Small Molecules

Mitigate downstream risk with expert services

Analytical testing services

  • Precise, end-to-end solutions with a complete suite of chemistry-based analytical testing services
  • All testing conducted according to current USP, EU and JP compendial methods
  • Our quality teams routinely audit our capabilities for strict cGMP compliance

Analytical method development and material release services

Leverage our regulatory, chemistry and advanced instrumentation expertise to support your analytical method development.

We deliver consultative reports, protocols and a skilled team working under cGMP.

Batch release and stability lot testing

Curia scientists work with strict compliance to cGMP requirements for Quality Control testing for drug release of pharmaceuticals and biopharmaceuticals. Our goal is to exceed quality, safety and regulatory standards.

Your trusted partner for package
and medical device testing

Distribution testing

As an independent service provider, we are a trusted partner for distribution testing, packaging materials qualification and product testing.
Our experts help you understand testing requirements, available test options and how to execute packaging validation projects on time and on budget.

Medical device testing

Our medical device testing and validation services for products, materials and packaging is offered with documentation to support your processes.
Our solutions ensure your devices meet all regulatory requirements and the highest
industry standards.

High-end analytic labs optimized for fast timelines

Curia has a full suite of analytical capabilities, including Nuclear Magnetic Resonance, Mass Spectrometry, and Chromatography. Our specialists use their expertise to deliver the robust data and insights needed to keep your product moving ahead.

Choose the best solid form for progression into trials

Our preformulation and material science expertise in characterizing and modifying a drug substance’s physical, chemical and mechanical properties helps you choose the best solid form for progression into animal and human dosing trials.

We also provide solid-state analysis and crystallization process development and troubleshooting as stand-alone services or an integrated solution.


Analyze and optimize your compound

Analytical method development and analytical assays to optimize design, capacity and execution

Comprehensive analytical method development meeting USP, Ph. EU., and FDA guidelines

Circumvent potential issues during late-stage development

Our antibody developability analysis includes biophysical and chemical properties assessment for your drug candidate early on to circumvent potential issues.

We use in silico predictive tools and a series of fast and small-scale assessments to serve as additional selection criteria for better and safe therapeutic leads.


Learn more

Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 29 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics.